SPIRITUS BIOSCIENCE
Spiritus Bioscience is a drug development company seeking to apply their proprietary drug-delivery technology to the Medicalized-Psilocybin market in Oregon
SPIRITUS BIOSCIENCE
Industry:
Biotechnology Clinical Trials Life Science Medical Therapeutics
Website Url:
http://www.spiritusbioscience.com
Total Employee:
1+
Status:
Active
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta SPF Google Font API Google Tag Manager WordPress Google Analytics SSL By Default Global Site Tag IPv6
Similar Organizations
Arctic Therapeutics
Arctic Therapeutics (AT) uses bioinformatic approaches and AI to eliminate major risks associated with traditional drug development.
Carisma Therapeutics
Carisma Therapeutics is a biotechnology company developing cellular immunotherapies to treat solid tumors.
Longevity Biotech
Longevity Biotech develops a new class of therapeutics via artificial protein technology that focuses on pharmaceutical preparation.
Peroxitech Therapeutics
Peroxitech Therapeutics operates as a biopharmaceutical company.
Spark Therapeutics
Spark Therapeutics is focused on the development of gene therapy.
Verismo Therapeutics
Verismo Therapeutics develops novel chimeric antigen receptors (CARs) that enhance T-cell-based cellular immunotherapy for cancer.
Investors List
Mystic Ventures
Mystic Ventures investment in Venture Round - Spiritus Bioscience
Mystic Ventures
Mystic Ventures investment in Seed Round - Spiritus Bioscience
Official Site Inspections
http://www.spiritusbioscience.com
- Host name: 185.158.133.1
- IP address: 185.158.133.1
- Location: Germany
- Latitude: 51.2993
- Longitude: 9.491
- Timezone: Europe/Berlin
More informations about "Spiritus Bioscience"
Spiritus Biosciences
Spiritus Biosciences is focused on improving patient experience by contouring drug delivery and patient experience with novel formulation and final form technology.. Our experienced team of formulation scientists and drug delivery …See details»
Spiritus Bioscience - Crunchbase Company Profile & Funding
Spiritus Bioscience is a drug development company seeking to apply their proprietary drug-delivery technology to the Medicalized-Psilocybin market in OregonSee details»
Spiritus Bioscience - LinkedIn
Spiritus Biosciences is focused on improving the patient experience by contouring drug delivery and patient experience with novel formulation and final form technology. Our experienced …See details»
Spiritus Bioscience - Drug pipelines, Patents, Clinical trials - Synapse
Spiritusbioscience.com. Last update 01 Nov 2024. Overview. Pipeline. Deal. Translational Medicine. Profit. Grant & Funding(NIH) Investment. Financing. Overview. Related. 100 Clinical …See details»
Spiritus Bioscience - Funding, Financials, Valuation & Investors
Aug 1, 2023 Organization. Spiritus Bioscience . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Funding Rounds 2. Lead …See details»
Company Information - RocketReach
Spiritusbioscience.com; 1 415987XXXX; View Similar People. Related Companies No related companies found at this time. Learn More How It Works. Get a Free Account. Sign up for a …See details»
Spiritus Bioscience - Updates, News, Events, Signals & Triggers
Aug 1, 2023 Proprietary Medical Psilocybin Delivery SystemsSee details»
Adam Chambers - Lab Director - Spiritus Bioscience - LinkedIn
After years spent in Cannabis refineries as a chemist, I moved on to technical sales for major processing equipment manufacturers. I've helped bring several multi state operated labs to …See details»
spiritusbioscience.com - Spiritus Biosciences - Spiritus Bioscience
Spiritusbioscience.com. Effective, patient-friendly psychedelic therapeutics have arrived.See details»
Spiritus Bioscience - 药物管线_专利_临床试验_投融营收
了解Spiritus Bioscience公司的药物管线，治疗领域，技术平台，以及它的1篇新闻。See details»
Spiritus Bio
Feb 21, 2021 Spiritus Bio Inc. -- Breathe Easier Under Masks. We are engineering the next generation of breathing systems to alleviate mask-related heat, humidity, CO2 inhalation, and skin irritation.See details»
Team - Spiritus
Dan Opila, Ph.D., P.E. Chief Architect, has a proven history of new product development and team leadership taking ideas from concept to mass production in renewable energy (over 2 …See details»
Spiritus - Company Profile - Tracxn
Dec 5, 2024 Spiritus - Provider of direct-air capture carbon removal solutions. Raised a total funding of $25.1M over 3 rounds from 4 investors. Founded by Charles Cadieu and Matthew …See details»
Spiritus Bioscience - Crunchbase
Proprietary Medical Psilocybin Delivery Systems. Carisma Therapeutics is a biotech company that develops novel chimeric antigen receptor macrophage technology to treat solid tumors.See details»
Join Us This Year in Miami - Wonderland
I have done extensive fieldwork in Latin America in ethno psychopharmacology and shamanic practice. I am currently Chief Scientific Officers at Aya Biosciences, a biopharmaceutical, data …See details»
Spiritus | Khosla Ventures backs effort to make orchards of lung …
The sorbent developed by Spiritus, made to mimick the human lung. ‘Mother nature’s the true artist’ Lee worked at Los Alamos National Lab from September 2012 to June 2022 on a …See details»
This Carbon Removal Startup Is Eyeing a Major Price Milestone
Vycarb uses a reactor to add limestone alkalinity to coastal ocean water, resulting in the drawdown and storage of atmospheric CO₂. Their dissolution system has a novel sensing …See details»
Spiritus - Overview, News & Similar companies | ZoomInfo.com
Dec 18, 2023 Spiritus Expands Leadership Team with Former Tesla, Meta and Exxon Executive to Lead Carbon Removal Infrastructure LOS ALAMOS, N.M.--(BUSINESS WIRE)--Spiritus, …See details»
Spiritus - Crunchbase Company Profile & Funding
Spiritus is a climate tech company developing direct-air-capture technology. Its approach combines the Spiritus Sorbent and the Spiritus Carbon Orchard, offering a scalable and …See details»
Innovative Climate Tech Company Spiritus Attracts Initial Investment
Daniel Lopez Partner San Francisco. Daniel advises private equity funds and their portfolio companies in the tech and life sciences sectors on various strategic transactions, including …See details»